Pulmonology

Inovoio Pharmaceuticals will assess INO-3107 to eventually become the first drug indicated for the rare disease.

New VDAART follow-up findings show at-risk children are not safer from asthma or recurrent wheeze when their mother takes prenatal vitamin D.

An analysis of the MESA study is shedding light on the potential association between having persistent asthma and developing atrial fibrillation.

Tiotropium reduces all-cause and asthma-related hospitalizations and emergency department visits.

The oral treatment becomes the first of its kind indicated for the reduction of food allergic reaction risks and severity in the US.

New research into the role of legislation on vaping use shows certain laws may be more effective than others.

New cohort data shows significantly worsened respiratory symptoms among patients with comorbid cough and COPD.

The FDA will rule on the type 2 inflammation-targeting biologic for another indication this May.

New data shows the market-controlling e-cigarette product nearly doubled its rate of young adult users in just 1 year.

New analysis feeds the belief that testosterone and estradiol influence asthma disparity between men and women.

A meta-analysis shows an association between respiratory burden and greater dementia risk, but the causes are still unknown.

New findings show patients with HDHPs are more likely to skip inhaler therapy due to costs, and are therefore more frequently hospitalized.

A long-term comparison trial with smokers motivated to quit show the combination of alternative nicotine products could slightly and safely improve cessation.

A comparison of virtual training to in-person education showed the former was noninferior to the latter among patients with asthma or COPD.

The US Food and Drug Administration has announced a comprehensive ban on flavored, pod-based e-cigarette cartridges earlier this week.

What the current critical care team looks like, and how it could be bettered.

A predictive assessment shows southern states will be the most burdened with rising rates of obesity and severe obesity—some nearing 60% of adults.

The compact delivery system is designed to reduce space needs for hospitals providing emergent care to patients with hypoxic respiratory failure associated with pulmonary hypertension.

A re-prioritization of disease monitoring and screening could help physicians better understand how one of the greatest killers in the US could be combated.

Results of the VESUVIUS trial are adding fuel to the fire in the debate over the impact of electronic cigarettes in former tobacco users.

An assessment of metoprolol in older patients with COPD had to be discontinued after treated patients reported a greater rate of hospitalization due to exacerbations.

The Senate voted 72-18 to support the successor to Scott Gottlieb, MD, following a November hearing which raised questions to his stance on proposed tobacco and e-cigarette policies.

A new study presented at ASH 2019 is providing further evidence for the use of weight-adjusted rivaroxaban in children with venous thromboembolism.

A new analysis has found the switch to the “increased-risk” donor classification by the US Public Health Service has had minimal impact on outcomes of lung transplants.

Artificial intelligence could provide physicians with easier, quicker measures of coronary artery calcium.